Published Date: 04 Dec 2024
While e-bikes have become highly popular for people who are trying to keep fit, researchers believe they can also make a significant difference for people recovering from cancer.
Read Full NewsOctober is Breast Cancer Awareness Month, a time to spotlight a disease that will affect hundreds of thousands of Americans this year. In the U.S., a new case of breast cancer is diagnosed about every two minutes, with more ...
Pancreatic neuroendocrine neoplasms (PNENs) are a rare form of cancer that affects hormone-producing cells in the pancreas. Although uncommon, their incidence has been rising steadily over the past few decades.
Invasive lung squamous cell carcinoma (LUSC) accounts for approximately one-quarter of all lung cancers, but therapeutic options for LUSC remain limited, primarily due to the absence of well-defined, targetable molecular ...
The American Cancer Society has released a report on occurrence and outcomes in the United States for this subtype of breast cancer. Findings show an estimated 33,600 women will be diagnosed with lobular breast cancer or ...
1.
Researchers explore e-bikes for cancer recovery
2.
BMI is linked to heart damage from chemotherapy in breast cancer patients.
3.
More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancer
4.
Research finds low uptake of supportive care at the end-of-life for patients with advanced cancer
5.
In inflammatory breast cancer, ER beta regulates estrogen signaling.
1.
Unlocking the Potential of Pirtobrutinib: A New Frontier in Cancer Treatment
2.
Nuclear Medicine's Role in Battling Women's Cancers
3.
Chronic Cancer Survivorship: Managing Long-Term Outcomes with Precision Care
4.
The benefits of using magnesium sulfate during pregnancy
5.
General Practitioners Role in Diagnosing Ovarian Cancer
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
4.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
5.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation